Protocole
The Protocole - A new era of modern wellness has arrived
New York, United States · $6.0M raised
- Headquarters
- New York
- Business Model
- B2C
- Website
- theprotocole.com
- Total Funding
- $6.0M
- Last Round
- $6.0M SeedApr 2026
- Rounds
- 1
About
Protocole is a New York-based telehealth platform offering personalized, physician-guided longevity protocols including NAD+, semaglutide, tirzepatide and glutathione therapies. Patients complete a medical intake reviewed by a licensed provider, and approved prescriptions are compounded and shipped by partner pharmacies. Co-founded by Delphine Le Grand and Cindy Yan, the company emerged from stealth in April 2026 with 6 million dollars in seed funding to build clinical-grade, membership-based access to peptide and longevity science.
Summary
Protocole is a Biotech company based in New York, United States. It has raised $6.0M in total across 1 round, most recently a $6.0M Seed round in Apr 2026.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2026
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/protocole"><img src="https://indexed.vc/api/badge/company/protocole" alt="Protocole on Indexed.vc" width="260" height="76" /></a>